Phase 1 Postherpetic Neuralgia Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Completed
Phase 1
A Phase I, Open-Label, Twice Daily Dose, Pharmacokinetic Study of EMA401 Sodium Salt Administered Orally in Healthy Elderly Subjects
Postherpetic Neuralgia
Spinifex Pharmaceuticals Pty Ltd8 enrolled1 locationACTRN12610000961044
Completed
Phase 1
A Phase I, Randomised, Open-Label, Three-way Crossover Comparative Pharmacokinetic Study of EMA401 Sodium Salt When Administered Orally in Fed (high fat meal or orange juice only) and Fasted Healthy Adult Males.
Postherpetic Neuralgia
Spinifex Pharmaceuticals Pty Ltd15 enrolled1 locationACTRN12610000798066
Completed
Phase 1
A Phase I Multiple Ascending Dose Study of EMA401 Sodium Salt Administered Orally in Healthy Elderly Subjects
Postherpetic Neuralgia
Spinifex Pharmaceuticals Pty Ltd32 enrolled1 locationACTRN12610000620022
Completed
Phase 1
A phase I, randomised, double-blind, placebo controlled, dose ranging study to evaluate the safety, tolerability and pharmacokinetics of EMA401 following multiple oral dosing in healthy male subjects.
Postherpetic Neuralgia
Spinifex Pharmaceuticals Pty Ltd36 enrolled1 locationACTRN12609000489291
Completed
Phase 1
A Phase I, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of EMA401 Following Single Ascending Oral Dosing of EMA401.Na in Healthy Volunteers Administered Orally in the Fasted and Fed State.
Postherpetic Neuralgia
Spinifex Pharmaceuticals Pty Ltd.36 enrolled1 locationACTRN12608000335392